Surprisingly, this qualifies as a balanced opinion. You seem to soften up a little.
I also didn't expect any SP movement after the CC.
There has to be a way to get FlutiCare out on the market without further dilution. Another public offering would be huge trouble for this stock. I doubt West-Ward will agree to a full deferred payment, but maybe Damaj will be able to negotiate an upfront payment with the rest being payed in Q1. After all this is a lucrative deal for both companies so I wouldn't discard the possibility of such an agreement. Alternatively, they could take out a smaller loan as was used for the BH acquisition. With FlutiCare and millions of revenue from other products in the bag, they should be able to get a loan with more humane conditions than previously.
In any case, FlutiCare has to take precedence and all product launches have to be shelved which could jeopardize FlutiCare financing.